ArticleFrontiers in cell and developmental biology2020

Schedule-Dependent Synergy Between the Histone Deacetylase Inhibitor Belinostat and the Dihydrofolate Reductase Inhibitor Pralatrexate in T-and B-cell Lymphoma Cells

Godefridus J Peters et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.